๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen

โœ Scribed by Werner Robert Bezwoda; Jan D. Esser; Roger Dansey; Ivan Kessel; Myron Lange


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
460 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Estrogen and progesterone receptors in t
โœ Andrea Manni; Baha'Uddin Arafah; Olof H. Pearson ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 302 KB ๐Ÿ‘ 1 views

This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (>3 fmoUmg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to

Estrogen receptor (ER) and progesterone
โœ Richard M. Elledge; Stephanie Green; Reginald Pugh; D. Craig Allred; Gary M. Cla ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 133 KB ๐Ÿ‘ 1 views

Results of estrogen receptor (ER) and progesterone receptor (PgR) ligand-binding assays (LBAs) are strongly correlated with ER and PgR by immuno-histochemistry (IHC). To investigate whether ER and PgR by IHC are also strongly correlated with tamoxifen response, time to treatment failure (TTF) and ov